Literature DB >> 520418

Antagonism of cholecystokinin-like peptides by opioid peptides, morphine or tetrodotoxin.

G Zetler.   

Abstract

Morphine, beta-endorphin, Met-enkephalin, and Leu-enkephalin antagonized intestinal actions of cholecystokinin octapeptide (CCK-8), caerulein, and pentagastrin in a manner partly suggesting physiologically competitive antagonism. Further, these acidic peptides (CCK-8, caerulein, pentagastrin) were much more sensitive to the actions of opioids than was angiotensin. Tetrodotoxin also caused changes in the concentration-effect curves, but these were different from the shifts due to the opioids and differentiated between CCK-8, caerulein, and pentagastrin. Naloxone did not modify the response to CCK-8 and caerulein, but completely abolished the antagonistic influence of the opioids. The potencies of morphine and the opioid peptides as antagonists of CCK-8, were of nearly the same order of magnitude. This and the presence in gut and brain of both CCK-like and opioid peptides suggests the hypothesis that these two groups of peptides interact on both myenteric and central nervous system receptors, and thus are directly involved in the regulation of both intestinal motility and satiety.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 520418     DOI: 10.1016/0014-2999(79)90053-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Effect of intracerebroventricular and systemic injections of caerulein, a CCK analogue, on electrical self-stimulation and its interaction with the CCKA receptor antagonist, L-364,718 (MK-329).

Authors:  M H Hamilton; I C Rose; L J Herberg; J S de Belleroche
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Effect of devazepide reversed antagonism of CCK-8 against morphine on electrical and mechanical activities of rat duodenum in vitro.

Authors:  Man-Ying Xu; Hui-Ming Lu; Shu-Zhen Wang; Wen-Yan Shi; Xin-Chun Wang; Dong-Xiao Yang; Chun-Xiao Yang; Li-Zhuang Yang
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

3.  Effects of ceruletide and cholecystokinin octapeptide on eating in mice. Interactions with naloxone and the enkephalin analogue, FK 33-824.

Authors:  G Zetler; K H Mörsdorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

4.  The release of rat intestinal cholecystokinin after oral trypsin inhibitor measured by bio-assay.

Authors:  S J Brand; R G Morgan
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

5.  Interactions of caerulein and morphine on gastrointestinal propulsion in the mouse.

Authors:  E Scheufler; G Zetler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

Review 6.  Comparative immunocytochemical localization of putative opioid ligands in the central nervous system.

Authors:  K Stengaard-Pedersen; L I Larsson
Journal:  Histochemistry       Date:  1981

Review 7.  Cholecystokinin and pain: a review.

Authors:  J W McRoberts
Journal:  Anesth Prog       Date:  1986 Mar-Apr

Review 8.  Multifunctional Opioid-Derived Hybrids in Neuropathic Pain: Preclinical Evidence, Ideas and Challenges.

Authors:  Joanna Starnowska-Sokół; Barbara Przewłocka
Journal:  Molecules       Date:  2020-11-25       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.